Literature DB >> 6769377

Estimates of essential neural elements for stimulation through a cochlear prosthesis.

B M Clopton, F A Spelman, J M Miller.   

Abstract

Electrical stimulation of afferent auditory pathways through electrodes placed within and outside of the cochlea were used to study stimulation and design parameters relevant to a cochlear prosthesis. In the acute guinea pig preparation, the tract response evoked in brachium of the inferior colliculus by electrical stimulation to an ear provided estimates of the effectiveness of various electrode placements. Stimulation between an electrode in the cochlea and a site along the eighth nerve was characterized by the lowest thresholds. Stimulation between intracochlear electrodes was somewhat less effective, and stimulation between external electrodes at the nerve, cochlear nucleus, or distant point was least effective. Thresholds, expressed as current, rose at approximately 6 dB per octave for stimulus frequencies from 1 kHz to 16 kHz. Thresholds below 10 microA rms were seen for optimal placements. These observations suggest that the neural elements being stimulated are the cell bodies of the spiral ganglion cells.

Entities:  

Mesh:

Year:  1980        PMID: 6769377     DOI: 10.1177/00034894800890s202

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  12 in total

1.  Electromotile hearing: acoustic tones mask psychophysical response to high-frequency electrical stimulation of intact guinea pig cochleae.

Authors:  Colleen G Le Prell; Kohei Kawamoto; Yehoash Raphael; David F Dolan
Journal:  J Acoust Soc Am       Date:  2006-12       Impact factor: 1.840

2.  Spatial selectivity to intracochlear electrical stimulation in the inferior colliculus is degraded after long-term deafness in cats.

Authors:  Maike Vollmer; Ralph E Beitel; Russell L Snyder; Patricia A Leake
Journal:  J Neurophysiol       Date:  2007-09-12       Impact factor: 2.714

3.  Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis.

Authors:  Robert W Eppsteiner; A Eliot Shearer; Michael S Hildebrand; Adam P Deluca; Haihong Ji; Camille C Dunn; Elizabeth A Black-Ziegelbein; Thomas L Casavant; Terry A Braun; Todd E Scheetz; Steven E Scherer; Marlan R Hansen; Bruce J Gantz; Richard J H Smith
Journal:  Hear Res       Date:  2012-08-28       Impact factor: 3.208

4.  Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy.

Authors:  Yohei Takada; Lisa A Beyer; Donald L Swiderski; Aubrey L O'Neal; Diane M Prieskorn; Shaked Shivatzki; Karen B Avraham; Yehoash Raphael
Journal:  Hear Res       Date:  2013-12-12       Impact factor: 3.208

5.  Audiological and Surgical Outcomes of Pediatric Cochlear Implantation in Mondini's Dysplasia: Our Experience.

Authors:  Abha Kumari; Senthil Vadivu Arumugam; Virender Malik; Sunil Goyal; Mohan Kameswaran
Journal:  J Int Adv Otol       Date:  2021-01       Impact factor: 1.017

6.  Ganglion cell and 'dendrite' populations in electric acoustic stimulation ears.

Authors:  Helge Rask-Andersen; Wei Liu; Fred Linthicum
Journal:  Adv Otorhinolaryngol       Date:  2009-11-25

7.  Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists.

Authors:  Qing Yu; Qing Chang; Xia Liu; Yunfeng Wang; Huawei Li; Shusheng Gong; Keqiang Ye; Xi Lin
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

8.  Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea.

Authors:  Yu Sun; Wenxue Tang; Qing Chang; Yunfeng Wang; Weijia Kong; Xi Lin
Journal:  J Comp Neurol       Date:  2009-10-20       Impact factor: 3.215

9.  7,8,3'-Trihydroxyflavone, a potent small molecule TrkB receptor agonist, protects spiral ganglion neurons from degeneration both in vitro and in vivo.

Authors:  Qing Yu; Qing Chang; Xia Liu; Shusheng Gong; Keqiang Ye; Xi Lin
Journal:  Biochem Biophys Res Commun       Date:  2012-05-07       Impact factor: 3.575

10.  Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.

Authors:  Darius Rejali; Valerie A Lee; Karen A Abrashkin; Nousheen Humayun; Donald L Swiderski; Yehoash Raphael
Journal:  Hear Res       Date:  2007-03-07       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.